Archer-Daniels-Midland Company ADM
Verdict: Sell. Fair value $74.04 against a price of $58.32 on 5 Jan 2026, 27% above the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power.
The case against: Intense competitive pressure could compress margins. ADM has faced DOJ/SEC investigations regarding accounting practices in its Nutrition segment.... Net Income declined 48.3% YoY ($3.48B to $1.80B) while Revenue declined only 8.9%, indicating....
Main risks
- Revenue contraction (-8.9% YoY) indicates cyclical downturn or market share loss
- Significant Net Margin deterioration (4.3% in 2022 to 2.1% currently)
- Negative ROIIC (-10%) suggests recent capital deployment has not yielded incremental earnings
- ADM has faced DOJ/SEC investigations regarding accounting practices in its Nutrition segment...
- Net Income declined 48.3% YoY ($3.48B to $1.80B) while Revenue declined only 8.9%, indicating...
- Intense competitive environment